GB Patent

GB0012370D0 — Peptoids

Assigned to Quadrant Holdings Cambridge Ltd · Expires 2000-07-12 · 26y expired

What this patent protects

Patent listed against bremelanotide-acetate.

Drugs covered by this patent

bremelanotide-acetate (BREMELANOTIDE ACETATE)

Patent Metadata

Patent number: GB0012370D0
Jurisdiction: GB
Classification: —
Expires: 2000-07-12
Drug substance claim: No
Drug product claim: No
Assignee: Quadrant Holdings Cambridge Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.